160
Participants
Start Date
December 20, 2019
Primary Completion Date
October 21, 2025
Study Completion Date
December 16, 2025
Apremilast
Apremilast dose will be increased from 20 mg BID to 30 mg BID for those subjects that reach a weight of 50 kg or more during the study
Centre Hospitalier Universitaire Saint Pierre, Brussels
Cliniques Universitaires Saint Luc, Brussels
General University Hospital of Alicante, Alicante
Universitair Ziekenhuis Gent, Ghent
Cabinet du Docteur Ruer-Mulard Mireille, Martigues
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milan
Hospital General Universitario Gregorio Maranon, Madrid
Hospital Infantil Universitario Nino Jesus, Madrid
Hospital 12 de Octubre, Madrid
Hospital La Paz, Madrid
Medical University of South Carolina, Charleston
Skin Care Physicians of Georgia, Macon
Centre Hospitalier Universitaire de Toulouse - Hopital Larrey, Toulouse
Solutions Through Advanced Research Inc, Jacksonville
Ciocca Dermatology, Miami
Azienda Ospedaliera di Padova, Padua
Hospital Marques de Valdecilla, Santander
Wright State Physicians, Fairborn
Dawes Fretzin Dermatology Group Inc, Indianapolis
Johnson Dermatology Clinic, Fort Smith
Driscoll Childrens Hospital, San Antonio
Phoenix Childrens Hospital, Phoenix
California Dermatology Institute, Thousand Oaks
First OC Dermatology, Irvine
Stanford University School of Medicine, Palo Alto
State Scientific Center for Dermatovenereology and Cosmetology, Moscow
Moscow Scientific Practical Center of Dermatology Venerology and Cosmetology, Moscow
National Medical Research Center for Children Health, Moscow
Yarosavl State Medical Academy, Yaroslavl
Pierre Wolkenshtein Skin Diseases Clinic LLC, Saint Petersburg
Saint Petersburg State Pediatric Medical University, Saint Petersburg
LLC PiterKlinika, Saint Petersburg
Clinical Dispensary of Dermatology and Venereology of Krasnodar Territory of the Ministry of Health, Krasnodar
Republican Clinical Dermatology and Venerology Dispensary, Kazan'
Bashkiria State Medical University, Ufa
Chelyabinsk Regional Clinical Skin and Venereal Dispensary, Chelyabinsk
Ural Scientific Research Institute of Dermatovenereology and Immunopathology, Yekaterinburg
LLC Medical Center Zdorovaya Semiya, Novosibirsk
Altai State Medical University, Barnaul
Soroka University Medical Center, Bear Sheva
University of Wisconsin Hospital and Clinics, Madison
Stollery Childrens Hospital, Edmonton
Winnipeg Clinic Dermatology Research, Winnipeg
Karma Clinical Trials, St. John's
AvantDerm, Toronto
Fakultni nemocnice Kralovske Vinohrady, Prague
Synexus Czech sro, Prague
Azienda Ospedaliero Universitaria Di Cagliari, Cagliari
Hospital Sant Joan de Deu, Esplugues de Llobregat
Hopsital Germans Trias I Pujol, Badalona
Lead Sponsor
Amgen
INDUSTRY